Zhejiang Apeloa Jiayuan Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is LEVETIRACETAM, with a corresponding US DMF Number 25005.
Remarkably, this DMF maintains an Active status since its submission on May 19, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 02, 2013, and payment made on March 26, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II